At a pe of 11-12 it seems a reasonable valuation. Selling due to less than perfect npat due to Capex invesments into their acquisition seem a little short sighted. Any opinions on this?
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game